Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Among men who’ve had a negative prostate biopsy, the velocity of increasing prostate specific antigen (PSA) levels is not helpful in deciding whether…
NEW YORK (Reuters Health) – Women with heavy menstrual bleeding may find that the levonorgestrel-releasing intrauterine system (Mirena; Bayer Schering) is more effective than oral medroxyprogesterone acetate in…
NEW YORK (Reuters Health) – The intensity of bortezomib-based regimens used to treat multiple myeloma in elderly patents can be reduced in order to lessen toxicity, without jeopardizing…
Fred Smith discusses the new technologies and tools that the CDC is utilizing to reach physicians and patients. He is a Senior Technologist in the Office of the…
Michelle Samplin-Salgado discusses the mission of AIDS.gov and how they disseminate their message. She is a New Media Strategist with AIDS.gov. For more information, please visit: AIDS.gov. Sponsored…
Georges E. Abou Khalil discusses the difficulties of organ procurement within minority populations. He is an analyst with Donate Life. To learn more about Donate Life Hollywood, please…
NEW YORK (Reuters Health) – Rapid fluid replenishment “remarkably” improves the detection rate of patent foramen ovale (PFO) by transesophageal echocardiography, a multicenter team reports in the American…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – Unless they are already on appropriate antibiotics, all women undergoing cesarean delivery should be given prophylactic antibiotics within an hour before the procedure,…
NEW YORK (Reuters Health) – Intravitreal injection of clindamycin and dexamethasone to treat active ocular toxoplasmosis appears to be an alternative, and perhaps preferable, to classic treatment with…
